Nicholas Reed Selected Research

Nicholas Reed Research Topics

Disease

9	Neoplasms (Cancer) 10/2021 - 01/2004
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 12/2017
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2015 - 01/2012
3	Hypertension (High Blood Pressure) 01/2022 - 11/2015
3	Diarrhea 10/2021 - 11/2013
3	Disease Progression 10/2021 - 11/2015
3	Ovarian Neoplasms (Ovarian Cancer) 11/2013 - 07/2010
2	Fatigue 10/2021 - 11/2015
2	Hearing Loss (Hearing Impairment) 01/2020 - 02/2019
2	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2016
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2019 - 03/2016
2	Carcinoid Tumor (Carcinoid) 01/2018 - 12/2017
2	Stomatitis 01/2018 - 12/2017
2	Neutropenia 12/2017 - 11/2015
2	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 09/2010
1	Hypotension (Low Blood Pressure) 01/2022
1	Neuroendocrine Carcinoma 01/2020
1	Atherosclerosis 01/2020
1	medullary Thyroid cancer 01/2019
1	Primitive Neuroectodermal Tumors (PNET) 01/2018
1	Nausea 01/2018
1	Asthenia 12/2017
1	Lymphopenia (Lymphocytopenia) 12/2017
1	Respiratory Insufficiency (Respiratory Failure) 12/2017
1	Thrombocytopenia (Thrombopenia) 12/2017
1	Weight Loss (Weight Reduction) 12/2017
1	Sepsis (Septicemia) 12/2017
1	Acute Kidney Injury (Acute Renal Failure) 12/2017
1	Medullary Carcinoma 03/2016
1	Tinnitus 01/2016
1	Epilepsy (Aura) 01/2016
1	Neuralgia (Stump Neuralgia) 01/2016
1	Febrile Neutropenia 11/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2015
1	Diabetes Complications 07/2015
1	Carcinoma (Carcinomatosis) 11/2013
1	Dehydration (Water Stress) 11/2013
1	Ovarian Epithelial Carcinoma 11/2013
1	Residual Neoplasm 09/2010

Drug/Important Bio-Agent (IBA)

4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 12/2017
2	vandetanib (ZD6474)IBA 01/2019 - 03/2016
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2019 - 03/2016
2	Everolimus FDA Link 01/2018 - 12/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2015 - 07/2010
2	Carboplatin (JM8)FDA LinkGeneric 11/2015 - 07/2010
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2022
1	lenvatinibIBA 10/2021
1	MicroRNAs (MicroRNA)IBA 04/2021
1	Retinaldehyde (Retinal)IBA 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Carcinoembryonic AntigenIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2018
1	dactolisibIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Lutetium-177IBA 12/2017
1	lutetium Lu 177 dotatateIBA 12/2017
1	pasireotideIBA 12/2017
1	Octreotide (Sandostatin)FDA LinkGeneric 12/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2017
1	Megestrol Acetate (Borea)FDA LinkGeneric 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	irosustatIBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 01/2016
1	cediranib (AZD2171)IBA 11/2015
1	Tyrosine Kinase InhibitorsIBA 11/2015
1	Pharmaceutical PreparationsIBA 11/2015
1	Insulin (Novolin)FDA Link 07/2015
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2013
1	etirinotecan pegolIBA 11/2013
1	liposomal doxorubicin (Doxil)FDA Link 11/2013
1	PlatinumIBA 11/2013
1	thiaclopridIBA 08/2013
1	Gemcitabine FDA Link 07/2010
1	epoetin betaIBA 01/2004

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2004
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2010
3	Radiotherapy 11/2018 - 09/2010
2	Brachytherapy 12/2012 - 01/2012
1	Aftercare (After-Treatment) 10/2021
1	Drug Tapering 10/2021
1	Hearing Aids (Hearing Aid) 02/2019
1	Intravenous Infusions 12/2017
1	Image-Guided Radiotherapy 12/2012
1	Neoadjuvant Therapy 05/2012
1	Trachelectomy 05/2012
1	Adjuvant Chemotherapy 09/2010
1	Adjuvant Radiotherapy 09/2010